Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress in simulation modelling for pharmacokinetics.

David E Leahy1

  • 1Cyprotex PLC, 15 Beech Lane, Macclesfield, SK10 2DR, Cheshire, UK. d.leahy@CYPROTEX.com

Current Topics in Medicinal Chemistry
|May 29, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-validation pitfalls when selecting and assessing regression and classification models.

Journal of cheminformatics·2014
Same author

Automation of decision making in drug design.

Drug discovery today. Technologies·2013
Same author

Chemical Descriptors Library (CDL): a generic, open source software library for chemical informatics.

Journal of chemical information and modeling·2008
Same author

Physiologically-based Kinetic Modelling (PBK Modelling): meeting the 3Rs agenda. The report and recommendations of ECVAM Workshop 63.

Alternatives to laboratory animals : ATLA·2008
Same author

Competitive Workflow: novel software architecture for automating drug design.

Current opinion in drug discovery & development·2007
Same author

Integrating in vitro ADMET data through generic physiologically based pharmacokinetic models.

Expert opinion on drug metabolism & toxicology·2006
Same journal

Cosmetic Products Containing Rutin: A Systematic Review of Patents from 2014 to 2024.

Current topics in medicinal chemistry·2026
Same journal

Overview of Immunotherapy in Lung Cancer: Present Landscape.

Current topics in medicinal chemistry·2026
Same journal

Exploration of a Novel Physicochemical Property Space for the Development of Antimalarial Drugs.

Current topics in medicinal chemistry·2026
Same journal

Computational Drug Design of Natural Product-Based Azole Hybrids for Multifactorial Diseases: Success Stories.

Current topics in medicinal chemistry·2026
Same journal

Simulated Natural Nanoparticles in Bai-Hu-Tang Decoction: Preparation, Characterization, Pharmacokinetics, and Antipyretic Effects.

Current topics in medicinal chemistry·2026
Same journal

Dolabellane Diterpenes from the Marine Brown Alga Dictyota dolabellana and their Potential Antiviral Activity.

Current topics in medicinal chemistry·2026
See all related articles

Physiologically-based pharmacokinetic (PBPK) models predict drug behavior in the body. This review covers PBPK modeling approaches for absorption, distribution, metabolism, and elimination (ADME), including complex tissues and drug-drug interactions.

Area of Science:

  • Pharmacokinetics and Drug Metabolism
  • Computational Biology
  • Systems Pharmacology

Background:

  • Physiologically-based pharmacokinetic (PBPK) models are crucial for predicting drug behavior in humans and other species.
  • These mechanistic models integrate physiological parameters with drug-specific information to simulate absorption, distribution, metabolism, and elimination (ADME).

Purpose of the Study:

  • To review existing simulation models for predicting human pharmacokinetics.
  • To explain the structure and mathematical details of PBPK models.
  • To discuss advanced modeling approaches for complex tissues and drug interactions.

Main Methods:

  • Review of literature on PBPK models.
  • Explanation of mathematical representations of organ blood flow and distribution.

Related Experiment Videos

  • Discussion of modeling techniques for specific tissues (e.g., liver, tumors) and transport processes (e.g., biliary secretion).
  • Overview of experimental and in silico methods for ADME property estimation.
  • Description of gastro-intestinal transit modeling and drug-drug interaction simulations.

    • Main Results:

    • PBPK models provide a mechanistic framework for understanding and predicting drug pharmacokinetics.
    • Various mathematical approaches exist for representing physiological processes and drug distribution.
    • Modeling can be extended to complex biological systems and drug-drug interactions.

    Conclusions:

    • PBPK modeling is a versatile tool for pharmacokinetic prediction across species.
    • The review highlights the evolution and application of PBPK models in drug development.
    • Advanced PBPK models can simulate complex physiological processes and predict drug interactions.